Selective serotonin reuptake inhibitors (SSRIs) are a class of antidepressants increasingly
prescribed to treat patients with clinical depression. As a result of the significant negative …

Worldwide, biologically active pharmaceuticals, such as psychoactive drugs, are routinely
detected in aquatic ecosystems. In this regard, selective serotonin reuptake inhibitors …

The functional conservation of important selective serotonin reuptake inhibitor (SSRI) targets
in non-target organisms raises concerns about their potential adverse effects on the …

Antidepressants are one of the most commonly prescribed pharmaceutical classes for the
treatment of psychiatric conditions. They act via modulation of brain monoaminergic …

Pharmaceutical contamination is an increasing problem globally. In this regard, the selective
serotonin reuptake inhibitors (SSRIs)—a group of antidepressants—are particularly …

Selective serotonin reuptake inhibitors (SSRIs) represent a class of pharmaceuticals
previously reported in aquatic ecosystems. SSRIs are designed to treat depression and …

Pharmaceuticals and personal care products (PPCPs) are found in measureable quantities
within the aquatic environment. Selective serotonin reuptake inhibitor (SSRI) …

Selective serotonin reuptake inhibitors (SSRIs) are among the pharmaceutical compounds
frequently detected in sewage treatment plant effluents and surface waters, albeit at very low …

Selective serotonin reuptake inhibitors (SSRIs) are currently the most prescribed class of
psychotropic medications. Their increased global manufacture and use have become …

Antidepressant (AD) drugs are widely prescribed for the treatment of psychiatric disorders,
including depression and anxiety disorders. The continuous use of ADs causes significant …